Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

52.98 -4.82 (-8.34%)

Streaming Delayed Price Updated: 1:06 PM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Wall Street Slips as Job Cuts and Shutdown Fears Shake Confidence ↗

November 07, 2025

Investors brace for weaker labor data and prolonged government paralysis while AI-fueled volatility rattles the markets.

Via Chartmill

MRNA Q3 Deep Dive: Cost Controls and Pipeline Progress Amid Declining COVID Vaccine Demand

November 07, 2025

Biotechnology company Moderna (NASDAQ:MRNA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s...

Via StockStory

mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast ↗

November 06, 2025

Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand declines.

Via Benzinga

Moderna Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below.

Via Benzinga

Topics Earnings

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗

November 06, 2025

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto...

Via Benzinga

Topics Artificial Intelligence

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

November 06, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Moderna Inc (NASDAQ:MRNA) Reports Q3 2025 Revenue Beat and Narrower-Than-Expected Loss ↗

November 06, 2025

Moderna's Q3 2025 earnings beat revenue estimates with $1.016B and a narrower loss. Shares rose on strong COVID vaccine sales and an improved 2025 financial outlook.

Via Chartmill

Topics Earnings

Moderna Surges; Covid Vaccine Sales Decline, But Top Expectations ↗

November 06, 2025

Moderna stock surged Thursday. Though third-quarter vaccine sales declined, they came in above expectations.

Via Investor's Business Daily

Moderna (NASDAQ:MRNA) Posts Better-Than-Expected Sales In Q3, Stock Soars

November 06, 2025

Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s full-year...

Via StockStory

Topics Artificial Intelligence Supply Chain

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 06, 2025

Via ACCESS Newswire

Services Sector Soars, Dispelling Economic Gloom and Fueling U.S. Stock Market Rally

November 05, 2025

Washington D.C., November 5, 2025 – The U.S. services sector has delivered a powerful jolt of optimism to financial markets, with robust Purchasing Managers' Index (PMI) data for October 2025 largely...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Moderna Earnings: What To Look For From MRNA

November 04, 2025

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Thursday before the bell. Here’s what investors should know.

Via StockStory

Moderna Stock Is Sliding Monday: What's Going On? ↗

November 03, 2025

Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

Via Benzinga

Stay informed with the top movers within the S&P500 index on Monday. ↗

November 03, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.

Via Chartmill

Why Moderna (MRNA) Stock Is Falling Today

November 03, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an...

Via StockStory

10 Health Care Stocks Whale Activity In Today's Session ↗

November 03, 2025

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

November 03, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Gapping S&P500 stocks in Monday's session ↗

November 03, 2025

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends.

Via Chartmill

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Via Benzinga

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

November 03, 2025

Via ACCESS Newswire

Why Moderna (MRNA) Stock Is Trading Lower Today

October 31, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock retreated, giving back some of the strong gains from the previous session that were fueled by...

Via StockStory

Exploring the top movers within the S&P500 index during today's session. ↗

October 31, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On? ↗

October 31, 2025

Moderna shares are trading lower Friday afternoon, giving back a portion of gains seen Thursday.

Via Benzinga

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

Topics Artificial Intelligence Supply Chain

AI Revolutionizes Pharma Supply Chains: A New Era of Localized Resilience and Efficiency

October 31, 2025

The pharmaceutical industry is experiencing a profound and immediate transformation as Artificial Intelligence (AI) becomes a strategic imperative for localizing supply chains, fundamentally enhancing...

Via TokenRing AI

Topics Artificial Intelligence Economy Fraud

Discover which S&P500 stocks are making waves on Friday. ↗

October 31, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.